<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<PRE>


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported): <u>April 10, 2008</u>


                        <u>Blonder Tongue Laboratories, Inc.</u>
             (Exact Name of registrant as specified in its charter)



          <u>Delaware</u>                        <u>1-14120</u>                 <u>52-1611421</u>
      (State or other             (Commission File Number)    (I.R.S. Employer
jurisdiction of incorporation)                               Identification No.)


                <u>One Jake Brown Road, Old Bridge, New Jersey 08857</u>
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: <u>(732) 679-4000</u>


                                 <u>Not Applicable</u>
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))





Item 2.06  Material Impairments.

     On April 10, 2008, the Board of Directors of Blonder  Tongue  Laboratories,
Inc.  (the  "Company")  made  the  decision  to  cease  the  operations  of  its
wholly-owned  subsidiary,  Hybrid  Networks,  LLC ("Hybrid"),  and liquidate its
assets.  The Company  plans to wind down the  operations  of Hybrid by August 1,
2008.

     Hybrid's business activities consist of the operation of video,  high-speed
data and/or telephony systems  ("Systems") at 4 multi-dwelling  unit communities
under  certain  right-of-entry  agreements  ("ROE  Agreements").  As part of the
Company's  on-going   implementation  of  its  strategic  plan,  management  has
continued to evaluate the impact and  long-term  viability of non-core  business
activities,  including the continued  operation of the Systems.  The decision of
the Board of Directors to  discontinue  Hybrid's  operations was based upon such
evaluation and the current cash flow and operating losses of Hybrid.

     Based on this  decision,  the  Company  concluded  on April 10, 2008 that a
non-cash  impairment charge in the amount of approximately  $400,000 is required
to  write-off  Hybrid's  assets,  which  includes  the  ROE  Agreements  and the
equipment  necessary  to  operate  the  Systems,  substantially  all of which is
installed at the applicable property location.

     As a result of ceasing the  operations  of Hybrid,  the Company  expects to
make cash  expenditures  of  approximately  $50,000 in connection with the early
termination of certain contracts and agreements  related to the operation of the
Systems.

Forward Looking Statements

     This report contains  forward-looking  statements within the meaning of The
Private  Securities  Litigation Reform Act of 1995. These statements are neither
promises nor guarantees, are based upon assumptions and estimates that might not
be realized and are subject to risks and  uncertainties  that could cause actual
results to differ materially from those in the forward looking statements. These
risks and  uncertainties  include,  but are not  limited to,  increases  in cash
expenditures related to discontinuing the operations of Hybrid and the Company's
ability  to  complete  this  process  by August 1,  2008.  There are a number of
factors  that may cause the  Company's  actual  results  to  differ  from  these
forward-looking  statements,  including  the  success  of  marketing  and  sales
strategies and new product development,  the price of raw materials, and general
economic  and  business  conditions.  Other  risks  and  uncertainties  that may
materially  affect the Company are provided in the Company's  annual  reports to
shareholders  and the Company's  periodic  reports filed with the Securities and
Exchange Commission from time to time, including reports on Forms 10-K and 10-Q.
Please refer to these  documents  for a more thorough  description  of these and
other risk factors.




                                       2




                                    SIGNATURE


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                  BLONDER TONGUE LABORATORIES, INC.


                  By<u>  /s/ Eric Skolnik</u>
                       Eric Skolnik
                       Senior Vice President and Chief Financial Officer

Date: April 16, 2008




</PRE>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "blonder8k041608.htm", "secsgml_size_bytes": 5337}]
{"company-data": {"conformed-name": "BLONDER TONGUE LABORATORIES INC", "cik": "0001000683", "assigned-sic": "3663", "irs-number": "521611421", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-14120", "film-number": "08760128"}, "business-address": {"street1": "ONE JAKE BROWN RD", "street2": "PO BOX 1000", "city": "OLD BRIDGE", "state": "NJ", "zip": "08857", "phone": "9086794000"}, "mail-address": {"street1": "ONE JAKE BROWN ROAD", "city": "OLD BRIDGE", "state": "NJ", "zip": "08857"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported):
April 10, 2008
Blonder Tongue Laboratories, Inc.
(Exact Name of registrant as specified in its charter)
Delaware
1-14120
52-1611421
(State or other             (Commission File Number)    (I.R.S. Employer
jurisdiction of incorporation)                               Identification No.)
One Jake Brown Road, Old Bridge, New Jersey 08857
(Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code:
(732) 679-4000
Not Applicable
(Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)

[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))

Item 2.06  Material Impairments.

     On April 10, 2008, the Board of Directors of Blonder  Tongue  Laboratories,
Inc.  (the  "Company")  made  the  decision  to  cease  the  operations  of  its
wholly-owned  subsidiary,  Hybrid  Networks,  LLC ("Hybrid"),  and liquidate its
assets.  The Company  plans to wind down the  operations  of Hybrid by August 1,
2008.

     Hybrid's business activities consist of the operation of video,  high-speed
data and/or telephony systems  ("Systems") at 4 multi-dwelling  unit communities
under  certain  right-of-entry  agreements  ("ROE  Agreements").  As part of the
Company's  on-going   implementation  of  its  strategic  plan,  management  has
continued to evaluate the impact and  long-term  viability of non-core  business
activities,  including the continued  operation of the Systems.  The decision of
the Board of Directors to  discontinue  Hybrid's  operations was based upon such
evaluation and the current cash flow and operating losses of Hybrid.

     Based on this  decision,  the  Company  concluded  on April 10, 2008 that a
non-cash  impairment charge in the amount of approximately  $400,000 is required
to  write-off  Hybrid's  assets,  which  includes  the  ROE  Agreements  and the
equipment  necessary  to  operate  the  Systems,  substantially  all of which is
installed at the applicable property location.

     As a result of ceasing the  operations  of Hybrid,  the Company  expects to
make cash  expenditures  of  approximately  $50,000 in connection with the early
termination of certain contracts and agreements  related to the operation of the
Systems.

Forward Looking Statements

     This report contains  forward-looking  statements within the meaning of The
Private  Securities  Litigation Reform Act of 1995. These statements are neither
promises nor guarantees, are based upon assumptions and estimates that might not
be realized and are subject to risks and  uncertainties  that could cause actual
results to differ materially from those in the forward looking statements. These
risks and  uncertainties  include,  but are not  limited to,  increases  in cash
expenditures related to discontinuing the operations of Hybrid and the Company's
ability  to  complete  this  process  by August 1,  2008.  There are a number of
factors  that may cause the  Company's  actual  results  to  differ  from  these
forward-looking  statements,  including  the  success  of  marketing  and  sales
strategies and new product development,  the price of raw materials, and general
economic  and  business  conditions.  Other  risks  and  uncertainties  that may
materially  affect the Company are provided in the Company's  annual  reports to
shareholders  and the Company's  periodic  reports filed with the Securities and
Exchange Commission from time to time, including reports on Forms 10-K and 10-Q.
Please refer to these  documents  for a more thorough  description  of these and
other risk factors.

                                       2

                                    SIGNATURE

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                  BLONDER TONGUE LABORATORIES, INC.

                  By
/s/ Eric Skolnik
Eric Skolnik
                       Senior Vice President and Chief Financial Officer

Date: April 16, 2008